Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig
- PMID: 7720182
- DOI: 10.1007/BF00685738
Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig
Abstract
The concentration of free cisplatin was followed in plasma, scala tympani perilymph and cerebrospinal fluid (CSF) after an intravenous injection (12.5 mg/kg) in guinea pigs. Liquid chromatography with postcolumn derivatization was used for quantitative determination of the drug. The distribution of cisplatin to CSF was fast; at 10 min after drug administration the concentration was 7 micrograms/ml and the CSF:plasma ratio was 0.37. Cisplatin seems to distribute more slowly to the perilymphatic compartment. The highest concentration measured was 4 micrograms/ml at 20 min after the injection, and the perilymph:plasma ratio was 0.40 at that time. The concentration-time curves generated for cisplatin in perilymph and CSF were similar. No accumulation in the perilymphatic compartment or CSF was observed.
Similar articles
-
Cochlear pharmacokinetics of cisplatin: an in vivo study in the guinea pig.Laryngoscope. 2013 Dec;123(12):3172-7. doi: 10.1002/lary.24235. Epub 2013 Jul 29. Laryngoscope. 2013. PMID: 23754209
-
High concentrations of thiosulfate in scala tympani perilymph after systemic administration in the guinea pig.Acta Otolaryngol. 2009 Feb;129(2):132-7. doi: 10.1080/00016480802116232. Acta Otolaryngol. 2009. PMID: 18607994
-
Effects of glycerol on sodium and potassium concentrations in guinea pig perilymph.Arch Otorhinolaryngol. 1981;230(2):177-80. doi: 10.1007/BF00456147. Arch Otorhinolaryngol. 1981. PMID: 7295177
-
[Blockage of cochlear aqueduct for examination of perilymph (guinea pig) (author's transl)].Arch Otorhinolaryngol. 1979;224(3-4):257-65. Arch Otorhinolaryngol. 1979. PMID: 526188 German.
-
Perilymph composition in scala tympani of the cochlea: influence of cerebrospinal fluid.Hear Res. 1989 Nov;42(2-3):265-71. doi: 10.1016/0378-5955(89)90150-0. Hear Res. 1989. PMID: 2606807
Cited by
-
Cool OtOprotective Ear Lumen (COOL) Therapy for Cisplatin-induced Hearing Loss.Otol Neurotol. 2021 Mar 1;42(3):466-474. doi: 10.1097/MAO.0000000000002948. Otol Neurotol. 2021. PMID: 33351563 Free PMC article.
-
Pharmacokinetics of sodium thiosulfate in Guinea pig perilymph following middle ear application.J Otol. 2018 Jun;13(2):54-58. doi: 10.1016/j.joto.2017.12.001. Epub 2018 Feb 9. J Otol. 2018. PMID: 30559765 Free PMC article.
-
Hydrogen Inhalation Protects against Ototoxicity Induced by Intravenous Cisplatin in the Guinea Pig.Front Cell Neurosci. 2017 Sep 13;11:280. doi: 10.3389/fncel.2017.00280. eCollection 2017. Front Cell Neurosci. 2017. PMID: 28955207 Free PMC article.
-
Intratympanic Dexamethasone Role in Hearing Protection in Cancer Patients.Cureus. 2023 Aug 28;15(8):e44299. doi: 10.7759/cureus.44299. eCollection 2023 Aug. Cureus. 2023. PMID: 37779780 Free PMC article.
-
Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity.J Natl Cancer Inst. 2009 Jan 7;101(1):37-47. doi: 10.1093/jnci/djn418. Epub 2008 Dec 30. J Natl Cancer Inst. 2009. PMID: 19116379 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources